Impaired osteogenesis of T1DM bone marrow-derived stromal cells and periosteum-derived cells and their differential in-vitro responses to growth factor rescue

[1]  J. Temenoff,et al.  Spatially localized recruitment of anti-inflammatory monocytes by SDF-1α-releasing hydrogels enhances microvascular network remodeling. , 2016, Biomaterials.

[2]  W. Hagopian,et al.  Blood-based signatures in type 1 diabetes , 2016, Diabetologia.

[3]  A. Poveshchenko,et al.  Proliferation, Migration, and Production of Nitric Oxide by Bone Marrow Multipotent Mesenchymal Stromal Cells from Wistar Rats in Hypoxia and Hyperglycemia , 2015, Bulletin of Experimental Biology and Medicine.

[4]  G. Karsenty,et al.  Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation , 2015, Cell.

[5]  M. Leonard,et al.  Type 1 Diabetes Is Associated With an Increased Risk of Fracture Across the Life Span: A Population-Based Cohort Study Using The Health Improvement Network (THIN) , 2015, Diabetes Care.

[6]  G. Karsenty,et al.  Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation , 2015, Cell.

[7]  A. Schwartz.  Marrow Fat and Bone: Review of Clinical Findings , 2015, Front. Endocrinol..

[8]  Louis C. Gerstenfeld,et al.  Fracture healing: mechanisms and interventions , 2015, Nature Reviews Rheumatology.

[9]  Jie Song,et al.  Amphiphilic degradable polymers for immobilization and sustained delivery of sphingosine 1-phosphate. , 2014, Acta biomaterialia.

[10]  Jie Song,et al.  A sulfated nanofibrous mesh supporting the osteogenic differentiation of periosteum-derived cells. , 2013, Journal of biomaterials and tissue engineering.

[11]  A. Sood,et al.  The BB Wistar Rat as a Diabetic Model for Fracture Healing , 2013, ISRN endocrinology.

[12]  Fu-qiang Zhang,et al.  Osteogenic potential of bone marrow stromal cells derived from streptozotocin-induced diabetic rats. , 2013, International journal of molecular medicine.

[13]  A. Ceriello.  The emerging challenge in diabetes: the "metabolic memory". , 2012, Vascular pharmacology.

[14]  Mohammed A AboElAsrar,et al.  Insulin-like growth factor-1 cytokines cross-talk in type 1 diabetes mellitus: relationship to microvascular complications and bone mineral density. , 2012, Cytokine.

[15]  Aileen J F King,et al.  The use of animal models in diabetes research , 2012, British journal of pharmacology.

[16]  Lutz Claes,et al.  Fracture healing under healthy and inflammatory conditions , 2012, Nature Reviews Rheumatology.

[17]  H. Arzate,et al.  High glucose concentrations alter the biomineralization process in human osteoblastic cells. , 2012, Bone.

[18]  J. Nyman,et al.  Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone. , 2011, Bone.

[19]  D. Lippner,et al.  The bone marrow microenvironment contributes to type I diabetes induced osteoblast death , 2011, Journal of cellular physiology.

[20]  S. Goldstein,et al.  Elastomeric osteoconductive synthetic scaffolds with acquired osteoinductivity expedite the repair of critical femoral defects in rats. , 2011, Tissue engineering. Part A.

[21]  David M Maahs,et al.  Epidemiology of type 1 diabetes. , 2010, Endocrinology and metabolism clinics of North America.

[22]  X. Zhang,et al.  Streptozotocin-induced diabetic rat-derived bone marrow mesenchymal stem cells have impaired abilities in proliferation, paracrine, antiapoptosis, and myogenic differentiation. , 2010, Transplantation proceedings.

[23]  N. Donos,et al.  The effect of diabetes mellitus on osseous healing. , 2010, Clinical oral implants research.

[24]  J. M. Ryu,et al.  High glucose regulates cyclin D1/E of human mesenchymal stem cells through TGF‐β1 expression via Ca2+/PKC/MAPKs and PI3K/Akt/mTOR signal pathways , 2010, Journal of cellular physiology.

[25]  Thomas A Einhorn,et al.  TNF-α Mediates Diabetes-Enhanced Chondrocyte Apoptosis During Fracture Healing and Stimulates Chondrocyte Apoptosis Through FOXO1 , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  T. Rőszer,et al.  Inflammation as death or life signal in diabetic fracture healing , 2010, Inflammation Research.

[27]  M. Saito,et al.  Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus , 2010, Osteoporosis International.

[28]  J. Simmons,et al.  Increased circulating IL-8 is associated with reduced IGF-1 and related to poor metabolic control in adolescents with type 1 diabetes mellitus. , 2009, Cytokine.

[29]  Ming Yan,et al.  Sonic hedgehog alleviates the inhibitory effects of high glucose on the osteoblastic differentiation of bone marrow stromal cells. , 2009, Bone.

[30]  D. Meldrum,et al.  High glucose concentration in cell culture medium does not acutely affect human mesenchymal stem cell growth factor production or proliferation. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[31]  B. Baroli.  From natural bone grafts to tissue engineering therapeutics: Brainstorming on pharmaceutical formulative requirements and challenges. , 2009, Journal of pharmaceutical sciences.

[32]  Sheldon S. Lin,et al.  rhBMP-2 Enhances the Bone Healing Response in a Diabetic Rat Segmental Defect Model , 2009, Journal of orthopaedic trauma.

[33]  C. Colnot,et al.  Skeletal Cell Fate Decisions Within Periosteum and Bone Marrow During Bone Regeneration , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  Kristine C. Jordan,et al.  IGF-1 and IGF-Binding Proteins and Bone Mass, Geometry, and Strength: Relation to Metabolic Control in Adolescent Girls With Type 1 Diabetes , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  R. Guldberg,et al.  A Perspective: Engineering Periosteum for Structural Bone Graft Healing , 2008, Clinical orthopaedics and related research.

[36]  J. Kanczler,et al.  Osteogenesis and angiogenesis: the potential for engineering bone. , 2008, European cells & materials.

[37]  M. Kassem,et al.  Effects of high glucose on mesenchymal stem cell proliferation and differentiation. , 2007, Biochemical and biophysical research communications.

[38]  Paul G Scott,et al.  Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and Angiogenesis , 2007, Stem cells.

[39]  J. Verhaeghe,et al.  Decreased osteoblast activity in spontaneously diabetic rats , 1997, Endocrine.

[40]  L. McCabe,et al.  Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. , 2007, Endocrinology.

[41]  Zhong-yi Wang,et al.  Effects of insulin-like growth factor I on the development of osteoblasts in hyperglycemia. , 2006, Diabetes research and clinical practice.

[42]  D. Balzi,et al.  Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. , 2005, American journal of physiology. Endocrinology and metabolism.

[43]  Sheldon S. Lin,et al.  The effects of local insulin delivery on diabetic fracture healing. , 2005, Bone.

[44]  Er-Wei Bai,et al.  Modeling error and stability of endothelial cytoskeletal membrane parameters based on modeling transendothelial impedance as resistor and capacitor in series. , 2005, American journal of physiology. Cell physiology.

[45]  Stanley N Cohen,et al.  Smurf2 up-regulation activates telomere-dependent senescence. , 2004, Genes & development.

[46]  S. Epstein,et al.  Osteoporosis and Diabetes Mellitus , 2004, Reviews in Endocrine and Metabolic Disorders.

[47]  Geoffrey C Gurtner,et al.  Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. , 2004, The American journal of pathology.

[48]  J. Frenette,et al.  Insulin-dependent diabetes impairs the inflammatory response and delays angiogenesis following Achilles tendon injury. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[49]  D. Greiner,et al.  Rat models of type 1 diabetes: genetics, environment, and autoimmunity. , 2004, ILAR journal.

[50]  D. Graves,et al.  A role for advanced glycation end products in diminished bone healing in type 1 diabetes. , 2003, Diabetes.

[51]  Sheldon S. Lin,et al.  The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[52]  D. Leroith,et al.  Circulating levels of IGF-1 directly regulate bone growth and density. , 2002, The Journal of clinical investigation.

[53]  J. Verhaeghe,et al.  Decreased osteoblast activity in spontaneously diabetic rats. In vivo studies on the pathogenesis. , 1997, Endocrine.

[54]  H. Tesluk,et al.  Effect of Insulin‐Like Growth Factor Type 1 on Critical‐Size Defects in Diabetic Rats , 1995, The Journal of craniofacial surgery.

[55]  C. Laughton.  Measurement of the specific lipid content of attached cells in microtiter cultures. , 1986, Analytical biochemistry.

[56]  P. Mackay,et al.  Spontaneous diabetes mellitus in the Bio-Breeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells. , 1986, The Journal of clinical investigation.

[57]  J. Lian,et al.  Osteocalcin: isolation, characterization, and detection. , 1984, Methods in enzymology.